| Literature DB >> 12114043 |
J H Walter1, F J White, S K Hall, A MacDonald, G Rylance, A Boneh, D E Francis, G J Shortland, M Schmidt, A Vail.
Abstract
In patients with phenylketonuria, blood phenylalanine concentration during childhood is the major determinant of cognitive outcome. Guidelines provide age-related recommendations for treatment. To ascertain the extent to which these aims are achievable, we audited results from four centres for the years 1994-2000. The median proportion of samples with phenylalanine concentrations above those recommended was less than 30% for those younger than age 10 years but almost 80% for those aged 15 years and older. Similarly, the median frequency of blood sampling, expressed as a proportion of that recommended, was more than 80% for patients younger than 10 years but less than 50% by age 15 years. Our results indicate the difficulty of maintaining control in phenylketonuria, especially in older rather than younger children.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12114043 DOI: 10.1016/s0140-6736(02)09334-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321